Clinical trials
Completed trials in Mali
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
160 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 15 |
| 2007 | 7 |
| 2008 | 8 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 7 |
| 2013 | 8 |
| 2014 | 8 |
| 2015 | 12 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 7 |
| 2021 | 14 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 160 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 54 |
| London School of Hygiene and Tropical Medicine | 10 |
| ANRS, Emerging Infectious Diseases | 5 |
| GlaxoSmithKline | 5 |
| Novartis Pharmaceuticals | 4 |
| U.S. Army Medical Research and Development Command | 4 |
| University of Maryland, Baltimore | 4 |
| Emory University | 3 |
| International Food Policy Research Institute | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 70 |
| Malaria, Falciparum | 30 |
| Infections | 8 |
| HIV Infections | 7 |
| COVID-19 | 5 |
| Diarrhea | 5 |
| Tuberculosis | 5 |
| Meningitis, Meningococcal | 4 |
| Parasitemia | 4 |
| Acquired Immunodeficiency Syndrome | 3 |
Trials
Showing 51 to 75 of 160. Each trial links to its page on Pharma Observatory.
60 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.